DOCSLIB.ORG

Zebrafish in Endocrine Systems: Recent Advances and Implications

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Zebrafish in Endocrine Systems: Recent Advances and Implications PH73CH09-Hammerschmidt ARI 7 January 2011 12:19 Zebrafish in Endocrine Systems: Recent Advances and Implications for Human Disease Heiko Lohr¨ 1 and Matthias Hammerschmidt1,2,3 1Institute for Developmental Biology, 2Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CEDAD), 3Center for Molecular Medicine Cologne (CMMC), University of Cologne, D-50923 Cologne, Germany; email: [email protected] Annu. Rev. Physiol. 2011. 73:183–211 Keywords The Annual Review of Physiology is online at hypothalamo-pituitary axis, energy homeostasis, sleep, stress response, physiol.annualreviews.org reproduction, osmoregulation This article’s doi: 10.1146/annurev-physiol-012110-142320 Abstract Copyright c 2011 by Annual Reviews. Since its introduction as a genetic vertebrate model system approxi- All rights reserved mately 30 years ago, the focus of zebrafish research has increasingly by U.S. EPA-AWBERC Library on 04/23/13. For personal use only. 0066-4278/11/0315-0183$20.00 shifted to questions that are also relevant for human development and disease. Here, we review the potential of the zebrafish as a model Annu. Rev. Physiol. 2011.73:183-211. Downloaded from www.annualreviews.org for human endocrine systems. A recent review compared the func- tions of the different endocrine systems and glands in zebrafish with those in other vertebrates, including humans, coming to the conclu- sion that major aspects are conserved. Here, we present an updated overview of this rapidly growing field of zebrafish research, focusing on the hypothalamo-pituitary axis, which links the central nervous sys- tem with the endocrine systems, and on major processes that are under (neuro)endocrine control and are the subject of intensive current re- search in other endocrine model organisms, such as feeding circuits and energy homeostasis, sleep, stress, reproduction, osmoregulation, and calcium homeostasis. Finally, we summarize the strengths and weak- nesses of zebrafish as a model for studying endocrine systems. 183 PH73CH09-Hammerschmidt ARI 7 January 2011 12:19 INTRODUCTION: THE established in zebrafish: TILLING (targeting ZEBRAFISH MODEL induced local lesions in genomes) and, more recently, zinc finger nuclease technology. The prime animal models for studies of Alternatively, specific gene products can be biomedically relevant questions of endocrine inactivated via injection of chemically modified systems are the rat and the mouse, mammals antisense morpholino oligonucleotides (MOs). like humans. Furthermore, the mouse is highly For endocrine systems, this approach is usually suitable for reverse genetics, such as condi- restricted to studying their early development, tional recombinant gene targeting. However, rather than their function, as MOs injected the zebrafish (Danio rerio), a member of the into fertilized eggs are effective only during Cyprinidae group of teleost, native to India and the first 3 to 5 days of development. Burma, and a popular pet fish, may offer crucial Transgenic approaches are used for spa- complementary strengths (for a recent review, tially and/or temporally controlled overexpres- see Reference 1). A major genetic advantage of sion studies, for fluorochrome labeling of spe- the zebrafish compared with nonfish vertebrate cific cell types and live in vivo imaging, and for model systems is its high suitability to forward toxin-driven specific cell ablations. In addition, genetics. Compared with the mouse, zebrafish again taking advantage of the transparency of are small (up to 5 cm in length), can be kept at fish, one can ablate cells with a laser. To al- much higher density, and are easy to maintain low targeted ablation and for control, such ab- under laboratory conditions. In addition, fecun- lation is usually done with transgenic lines in dity is much higher, with single females giving which particular cell lineages are labeled with a weekly clutches of 100 to 500 synchronously fluorochrome (2). developing eggs. Like mice, zebrafish reach Finally, the zebrafish has become a power- sexual maturity at an age of approximately ful system for small-compound screening. This 3 months. However, zebrafish embryonic application again takes advantage of the rela- development is much faster, and most organs, tively small body size of the fish and the possi- including glands, are formed within the first bility of keeping larvae in 96 or 384 well dishes 5 days of development, when fish are only a for large-scale drug testing. This makes the ze- few millimeters long. Together, this makes the brafish a prime organism for pharmacological zebrafish an ideal system for large-scale and toxicity testing (3). As more and more mutant high-throughput mutagenesis screens, allow- zebrafish models for human diseases become ing the identification of novel essential genes on available, the use of zebrafish for therapeutic the basis of the phenotypes caused by randomly screening and de novo drug discovery is likely induced mutations. Mutations are usually intro- by U.S. EPA-AWBERC Library on 04/23/13. For personal use only. to increase (4–6). duced via the chemical N-ethyl-N-nitrosourea More detailed descriptions of all these tech- (ENU) or via different insertional approaches, Annu. Rev. Physiol. 2011.73:183-211. Downloaded from www.annualreviews.org niques and the respective references can be and techniques for subsequent cloning of the found in the Supplemental Text (follow Supplemental Material affected genes are well established. For many the Supplemental Material link from the purposes, phenotype screening can be done via Annual Reviews home page at http://www. visual inspection, taking advantage of the trans- annualreviews.org). We refer to several of parency of zebrafish larvae. Alternatively, spe- these technologies as we describe the differ- cific cell types can be labeled, for instance, via ent endocrine systems and hormone-controlled whole mount in situ hybridizations, immuno- processes in the following sections, and we re- stainings, or transgene-encoded fluoro- turn to these technologies at the end of this chromes. Furthermore, behavioral assays have review when we summarize the strengths and been established. weaknesses of the zebrafish as a model for en- In addition to forward genetics, differ- docrine systems. ent reverse-genetics approaches have been 184 Lohr¨ · Hammerschmidt PH73CH09-Hammerschmidt ARI 7 January 2011 12:19 THE HYPOTHALAMO- circadian rhythms, and/or energy homeostasis PITUITARY AXIS (7–10). As described in more detail below, all hypothalamo-pituitary axes also appear to exist The hypothalamo-pituitary axis constitutes the AH: adenohypophysis in zebrafish, and all seem to act in tight coop- physiological and anatomical link between the eration with other neuroendocrine systems in NH: neurohypophysis central nervous system (CNS), represented by control of body physiology (Figure 1). ARC: arcuate nucleus the hypothalamus, and the endocrine system, TRH: thyrotropin- represented by its master gland, the pituitary, releasing hormone also termed the hypophysis. The pituitary CRH: corticotropin- regulates a whole array of basic physiological The Neuroendocrine Hypothalamus releasing hormone processes involved in body homeostasis and The concept of neurosecretion dates back to GHRH: growth reproduction and consists of two parts, the 1928, when a young doctoral student at the hormone–releasing adenohypophysis (AH) and the neurohypoph- University of Munich, Ernst Scharrer, ob- hormone ysis (NH) (see below for details). In this axis, served specialized neurons in the CNS of the GnRH: particular neuroendocrine cells of the hy- teleost Phoxinus laevis (minnow) that secreted gonadotropin- pothalamus control the activity of the different hormones into the bloodstream. In hindsight, releasing hormone adenohypophyseal cell types via specific releas- this was a revolutionary discovery that demon- DA: dopamine ing or release-inhibiting hormones, to which strated the presence of neuroendocrine cells. adenohypophyseal cells respond by secretion Today, it is known that specialized neuronal of their own hormones to evoke peripheral cells in the mammalian hypothalamus inner- gland or end-organ responses, including vate the pituitary and release neuroactive sub- negative feedback loops to the hypothalamus stances, mostly peptides, into the bloodstream and pituitary. In addition, the hypothalamus to act in a hormonal fashion. generates direct effector hormones, which are In the mammalian hypothalamus, two types secreted via the NH (Figure 1). Prominent of neuroendocrine systems that project into glands under adenohypophyseal control are the or toward the pituitary—the parvocellular and cortex of the adrenal gland, which generates the magnocellular systems—can be distin- glucocorticoid hormones like cortisol; the guished. Parvocellular neuroendocrine cells thyroid, which generates thyroid hormones are located in several hypothalamic nuclei (T3 and T4); and the gonads, which generate lining the third ventricle and include the sex steroid hormones (testosterone, estrogen, arcuate nuclei (ARC), tuberal nuclei, anterior and progesterone). Therefore, many authors periventricular nuclei, and preoptic nuclei as prefer to further subdivide the axis into, for well as paraventricular nuclei (PVN). The par- instance, the hypothalamo-pituitary-adrenal vocellular neuroendocrine system comprises by U.S. EPA-AWBERC Library on 04/23/13. For personal use only. (HPA) axis, also termed the hypothalamo- six different neurohormones, all of which are pituitary-interrenal (HPI)
Load more

Recommended publications
  • Corticotropin-Releasing Hormone Physiology
    European Journal of Endocrinology (2006) 155 S71–S76 ISSN 0804-4643 Corticotropin-releasing hormone physiology Joseph A Majzoub Division of Endocrinology, Children’s Hospital Boston, Thomas Morgan Rotch Professor of Pediatrics, Harvard Medical School, 300 Longwood Avenue, Boston, Massachusetts 02115, USA (Correspondence should be addressed to J A Majzoub; Email: [email protected]) Abstract Corticotropin-releasing hormone (CRH), also known as corticotropin-releasing factor, is a highly conserved peptide hormone comprising 41 amino acid residues. Its name derives from its role in the anterior pituitary, where it mediates the release of corticotropin (ACTH) leading to the release of adrenocortical steroids. CRH is the major hypothalamic activator of the hypothalamic–pituitary– adrenal (HPA)axis. Major functions of the HPAinclude: (i) influencing fetal development of major organ systems including lung, liver, and gut, (ii) metabolic functions, including the maintenance of normal blood glucose levels during the fasting state via glycogenolysis and gluconeogenesis, (iii) modulation of immune function, and (iv) maintenance of cardiovascular tone. In addition, CRH, acting both directly and via the HPA, has a role in regulating several neuroendocrine functions including behavior, food intake, reproduction, growth, immune function, and autonomic function. CRH has been localized to the paraventricular nucleus (PVN) of the hypothalamus, which projects to the median eminence and other hypothalamic and midbrain targets. The CRH gene is composed of two exons. The CRH promoter contains a cAMP-response element, and the intron contains a restrictive element-1/neuron restrictive silencing element (RE-1/NRSE) sequence. Recently, a family of CRH-related peptides, termed the urocortins, has been identified.
    [Show full text]
  • Associations Between Serum Leptin Level and Bone Turnover in Kidney Transplant Recipients
    Associations between Serum Leptin Level and Bone Turnover in Kidney Transplant Recipients ʈ ʈ ʈ Csaba P. Kovesdy,*† Miklos Z. Molnar,‡§ Maria E. Czira, Anna Rudas, Akos Ujszaszi, Laszlo Rosivall,‡ Miklos Szathmari,¶ Adrian Covic,** Andras Keszei,†† Gabriella Beko,‡‡ ʈ Peter Lakatos,¶ Janos Kosa,¶ and Istvan Mucsi §§ *Division of Nephrology, Salem Veterans Affairs Medical Center, Salem, Virginia; †Division of Nephrology, University of Virginia, Charlottesville, Virginia; ‡Institute of Pathophysiology, Semmelweis University, Budapest, Hungary; §Harold Simmons Center for Chronic Disease Research & Epidemiology, Los Angeles Biomedical Research Institute at ʈ Harbor-University of California–Los Angeles Medical Center, Torrance, California; Institute of Behavioral Sciences, Semmelweis University, Budapest, Hungary; ¶First Department of Internal Medicine, Semmelweis University, Budapest, Hungary; **University of Medicine Gr T Popa, Iasi, Romania; ††Department of Epidemiology, Maastricht University, Maastricht, Netherlands; ‡‡Central Laboratory, Semmelweis University, Budapest, Hungary; and §§Division of Nephrology, Department of Medicine, McGill University Health Center, Montreal, Quebec, Canada Background and objectives: Obesity is associated with increased parathyroid hormone (PTH) in the general population and in patients with chronic kidney disease (CKD). A direct effect of adipose tissue on bone turnover through leptin production has been suggested, but such an association has not been explored in kidney transplant recipients. Design, setting, participants, & measurements: This study examined associations of serum leptin with PTH and with biomarkers of bone turnover (serum beta crosslaps [CTX, a marker of bone resorption] and osteocalcin [OC, a marker of bone formation]) in 978 kidney transplant recipients. Associations were examined in multivariable regression models. Path analyses were used to determine if the association of leptin with bone turnover is independent of PTH.
    [Show full text]
  • Endocrine System WS19
    Endocrine System Human Physiology Unit 3 Endocrine System • Various glands located throughout the body • Some organs may also have endocrine functions • Endocrine glands/organs synthesize and release hormones • Hormones travel in plasma to target cells Functions of the Endocrine System • Differentiation of nervous and reproductive system during fetal development • Regulation of growth and development • Regulation of the reproductive system • Maintains homeostasis • Responds to changes from resting state Mechanisms of Hormone Regulation • Hormones have different rates and rhythms of secretion • Hormones are regulated by feedback systems to maintain homeostasis • Receptors for hormones are only on specific effector cells • Excretion of hormones vary for steroid hormones and peptide hormones Regulation of Hormone Secretion • Release of hormones occurs in response to • A change from resting conditions • Maintaining a regulated level of hormones or substances • Hormone release is regulated by • Chemical factors (glucose, calcium) • Endocrine factors (tropic hormones, HPA) HPA = Hypothalamic-Pituitary Axis • Neural controls (sympathetic activation) Hormone Feedback Systems Negative feedback maintains hormone concentrations within physiological ranges • Negative feedback • Feedback to one level Loss of • Long-loop Negative Feedback feedback • Feedback to two levels control often leads to • Hypothalamus-Pituitary-Gland Axis pathology Negative Feedback Short-Loop Negative Feedback Long-Loop Negative Feedback Hormone Transport Peptide/Protein Hormones
    [Show full text]
  • The ENDOCRINE SYSTEM Luteinizinghormones Hormone/Follicle-Stimulating Are Chemical Hormone Messengers
    the ENDOCRINE SYSTEM LuteinizingHormones hormone/follicle-stimulating are chemical hormone messengers. (LH/FSH) They bind to specific target cells Crucial for sex cell production Growth hormone–releasingwith receptors, hormone regulate (GHRH) metabolism and the sleep cycle, and contribute Thyrotropin-releasing hormone (TRH) Regulatesto thyroid-stimulating growth and hormone development. release The endocrine glands and organs secrete Corticotropin-releasing hormone (CRH) Regulatesthese to release hormones of adrenocorticotropin all over that is vitalthe to body. the production of cortisol (stress response hormone). The hypothalamus is a collection of specialized cells that serve as the central relay system between the nervous and endocrine systems. hypothalamus Growth hormone-releasing hormone (GHRH) Thyrotropin-releasing hormone (TRH) Regulates the release of thyroid-stimulating hormones Luteinizing hormone/follicle-stimulating hormone (LH/FSH) Crucial for sex cell production Corticotropin-releasing hormone (CRH) Regulates the release of adrenocorticotropin that’s vital to the production of cortisol 2 The hypothalamus translates the signals from the brain into hormones. From there, the hormones then travel to the pituitary gland. Located at the base of the brain inferior to the hypothalamus, the pituitary gland secretes endorphins, controls several other endocrine glands, and regulates the ovulation and menstrual cycles. pituitary gland 3 The anterior lobe regulates the activity of the thyroid, adrenals, and reproductive glands by producing hormones that regulate bone and tissue growth in addition to playing a role in the absorption of nutrients and minerals. anterior lobe Prolactin Vital to activating milk production in new mothers Thyrotropin Stimulates the thyroid to produce thyroid hormones vital to metabolic regulation Corticotropin Vital in stimulating the adrenal gland and the “fight-or-flight” response 4 The posterior lobe stores hormones produced by the hypothalamus.
    [Show full text]
  • Endocrine Paraneoplastic Syndromes: a Review
    Endocrinology & Metabolism International Journal Review Article Open Access Endocrine paraneoplastic syndromes: a review Abstract Volume 1 Issue 1 - 2015 Paraneoplastic endocrine syndromes result from ectopic production of hormones by Hala Ahmadieh,1 Asma Arabi2 different tumors. Hypercalcemia of malignancy is the most common, mostly caused by 1Division of Endocrinology, American University of Beirut, ectopic parathyroid hormone related peptide (PTHrP) production which increases bone Lebanon resorption. Other causes include the rare ectopic parathyroid hormone (PTH) production, 2Department of Internal Medicine, American University of ectopic production of 1, 25-(OH)2 vitamin D by the tumor and its adjacent macrophages and Beirut-Medical Center, Lebanon bone metastasis which by itself in addition to the local production of PTHrP at the level of the bone lead to bone resorption and thus hypercalcemia. Treatment includes extracellular Correspondence: Asma Arabi, Department of Internal fluid volume repletion, bisphosphonates or denosumab and calcitonin. Ectopic Cushing’s Medicine, Division of Endocrinology, American University of syndrome caused by ectopic ACTH production results in hypokalemia, proximal muscle Beirut-Medical Center, Po Box 11-0236, Riad El-Solh, Beirut, weakness, easy bruisability, hypertension, diabetes and psychiatric abnormalities including Lebanon, Email depression and mood disorders. Different diagnostic measures help to differentiate Cushing’s disease from ectopic Cushing’s syndrome. Treatment includes surgical resection Received: October 26, 2014 | Published: January 02, 2015 of tumor and medical therapy to suppress excess cortisol production. Ectopic secretion of ADH has been associated with different tumor types. The best treatment options include removal of the underlying tumor, chemotherapy, or radiotherapy in addition to free water restriction, demeclocycline and vaptans.
    [Show full text]
  • Physiological Adaptations in Pregnancy-Resources Table
    Responsibility/ Adaptations in Pregnancy Additional Information Hormones ➢ Maintaining homeostasis Perinatal Nursing – 2021 ➢ Regulation of growth Simpson, Creehan, O’Brien-Abel, Roth ➢ Development and Cellular communication & Rohan Chapter three – Physiological Changes of Pregnancy Blackburn, Susan Tucker Page 48 Placenta ➢ Responsible for transfer of nutrients to the fetus ❖ Placental Hormones are critical and waste products away from the fetus for many of the metabolic and ➢ Functions as the fetal lungs, gi, liver, kidney and endocrine changes during endocrine organ pregnancy ➢ Major Hormones ❖ Fetal bone growth and placental ❖ hCG - Human chorionic gonadotropin calcium transport is mediated ❖ hPL – Human Placental Lactogen by Parathyroid hormone related ❖ Estrogen protein or PTHrP ❖ Progesterone ❖ Corticotrophin-releasing ❖ Serves as an endocrine gland hormone or CRH and PGs have a ❖ Major Hormones major role in initiation of ❖ hCG - Human chorionic gonadotropin myometrial contractility and ❖ hPL – Human Placental Lactogen labor onset ❖ Estrogen Page 49 ❖ Progesterone ➢ HCG ➢ Primarily secreted by the placenta Page 49 1 | P a g e ➢ Major function is to maintain progesterone and estrogen production by the corpus luteum until the placental function is adequate (approximately 10 weeks post-conception) ➢ Thought to have a role in fetal testosterone and corticosteroid production and angiogenesis ➢ Found in maternal serum by within 7-8 days after implantation ➢ Positive pregnancy test – 3 weeks after conception and 5 weeks after LMP ➢ Elevated
    [Show full text]
  • G Protein-Coupled Receptors
    S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. British Journal of Pharmacology (2015) 172, 5744–5869 THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: G protein-coupled receptors Stephen PH Alexander1, Anthony P Davenport2, Eamonn Kelly3, Neil Marrion3, John A Peters4, Helen E Benson5, Elena Faccenda5, Adam J Pawson5, Joanna L Sharman5, Christopher Southan5, Jamie A Davies5 and CGTP Collaborators 1School of Biomedical Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK, 2Clinical Pharmacology Unit, University of Cambridge, Cambridge, CB2 0QQ, UK, 3School of Physiology and Pharmacology, University of Bristol, Bristol, BS8 1TD, UK, 4Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK, 5Centre for Integrative Physiology, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2015/16 provides concise overviews of the key properties of over 1750 human drug targets with their pharmacology, plus links to an open access knowledgebase of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. The full contents can be found at http://onlinelibrary.wiley.com/doi/ 10.1111/bph.13348/full. G protein-coupled receptors are one of the eight major pharmacological targets into which the Guide is divided, with the others being: ligand-gated ion channels, voltage-gated ion channels, other ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading.
    [Show full text]
  • JAGE-691 Fish Cognition and Consciousness Colin Allen [email protected] Phone
    JAGE-691 Fish Cognition and Consciousness Colin Allen [email protected] phone: +1-812-606-0881 fax: +1-812-855-3631 Program in Cognitive Science and Department of History and Philosophy of Science Indiana University, Bloomington, IN 47405 USA ABSTRACT. Questions about fish consciousness and cognition are receiving increasing attention. In this paper, I explain why one must be careful to avoid drawing conclusions too hastily about this hugely di- verse set of species. Keywords. Fish, learning, cognition, consciousness 1. Introduction to the controversy The cognitive and mental capacities of fish are a current topic of scientific controversy, and consciousness is the most contentious of topics. In a recent review article, Michel Cabanac and coauthors (Cabanac et al. 2009) argue that consciousness did not emerge until the early Amniota, the group of species that includes mammals, birds, and "reptiles.” The latter term is in scare quotes because biologists consider it a paraphy- letic group (i.e., a group that contains just a subset of the descendants of its common ancestor) that is im- proper for classification purposes due to its exclusion of the birds, which descended from the saurians. Amniotes are characterized by an embryonic membrane that makes terrestrial reproduction feasible. The amphibians, lacking this adaptation, are constrained to place their eggs in an aqueous environment for proper development. These biological details are important because of the nature of some of the evidence that Cabanac et al. bring to bear on the question of consciousness in fish – evidence that I shall maintain seems skewed towards other adaptations that have to do with terrestrial life.
    [Show full text]
  • Neuropeptide-Induced Contraction and Relaxation of the Mouse
    Proc. Natl. Acad. Sci. USA Vol. 81, pp. 625-629, January 1984 Physiological Sciences Neuropeptide-induced contraction and relaxation of the mouse anococcygeus muscle (neurohypophysial peptides/neurotensin/thyrotropin-releasing hormone/urotensin i/vasoactive intestinal polypeptide) ALAN GIBSON*, HOWARD A. BERNtt, MICHAEL GINSBURG*, AND JACK H. BOTTING* *Department of Pharmacology, Chelsea College, University of London, Manresa Road, London SW3 6LX, United Kingdom; and tDepartment of Zoology and Cancer Research Laboratory, University of California, Berkeley, CA 94720 Contributed by Howard A. Bern, September 26, 1983 ABSTRACT Isometric tension responses to neuropeptides fects of a wide range of neuropeptides on tone of the mouse were recorded from anococcygeus muscles isolated from male anococcygeus in vitro. mice. This smooth muscle tissue is innervated by inhibitory nonadrenergic, noncholinergic nerves that resemble, ultra- MATERIALS AND METHODS structurally, the peptidergic neurons of the gastrointestinal Male mice (LACA strain from A. Tuck & Son, Battles- tract; the physiological function of the anococcygeus is not bridge, Essex, U.K.; 25-35 g) were stunned and bled. Both known. Slow sustained contractions were produced by oxyto- anococcygeus muscles were dissected from the animal and cin (0.2-20 nM), [Arg8]vasopressin (0.4-200 nM), and [Arg]- set up in series, joined at the point of unification on the ven- vasotocin (0.4-100 nM); the mouse anococcygeus is, therefore, tral rectum, in 1-ml glass organ baths that contained Krebs one of the few examples of nonvascular smooth muscle from bicarbonate solution (mM: NaCl, 118.1; KCI, 4.7; MgSO4, male mammals to respond to low concentrations of oxytocin 1.0; KH2PO4, 1.2; CaCl2, 2.5; NaHCO3, 25.0; glucose, 11.1).
    [Show full text]
  • Urocortin 2 Autocrine/Paracrine and Pharmacologic Effects to Activate AMP-Activated Protein Kinase in the Heart
    Urocortin 2 autocrine/paracrine and pharmacologic effects to activate AMP-activated protein kinase in the heart Ji Lia, Dake Qib, Haiying Chengc, Xiaoyue Hub, Edward J. Millerd, Xiaohong Wub, Kerry S. Russellb, Nicole Mikushb, Jiasheng Zhangb, Lei Xiaoe, Robert S. Sherwinc, and Lawrence H. Youngb,1 aDepartment of Pharmacology and Toxicology, University at Buffalo, The State University of New York, Buffalo, NY 14214; bSection of Cardiovascular Medicine and cSection of Endocrinology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520; dDepartment of Medicine, Boston University, Boston, MA 02118; and eUniversity of Florida Shands Cancer Center, Department of Anatomy and Cell Biology, College of Medicine, Gainesville, FL 32610 Edited* by Gerald I. Shulman, Howard Hughes Medical Institute and Yale University, New Haven, CT, and approved August 9, 2013 (received for review July 11, 2013) Urocortin 2 (Ucn2), a peptide of the corticotropin-releasing factor Ucn2 (5). Signaling pathways have substantial cross-talk, and (CRF) family, binds with high affinity to type 2 CRF receptors pharmacologic inhibitor studies suggest a possible association (CRFR2) on cardiomyocytes and confers protection against ische- between activation of PKCe and the energy-stress kinase AMP- mia/reperfusion. The mechanisms by which the Ucn2-CRFR2 axis activated protein kinase (AMPK) (10). AMPK is activated by mitigates against ischemia/reperfusion injury remain incompletely changes in cellular energetics, but its activity is also modulated
    [Show full text]
  • Neuropeptide Regulation of Signaling and Behavior in the BNST
    Mol. Cells 2015; 38(1): 1-13 http://dx.doi.org/10.14348/molcells.2015.2261 Molecules and Cells http://molcells.org Established in 1990G Neuropeptide Regulation of Signaling and Behavior in the BNST Thomas L. Kash*, Kristen E. Pleil, Catherine A. Marcinkiewcz, Emily G. Lowery-Gionta, Nicole Crowley, Christopher Mazzone, Jonathan Sugam, J. Andrew Hardaway, and Zoe A. McElligott Recent technical developments have transformed how neu- aversion related behaviors, however there is also evidence that roscientists can probe brain function. What was once it can regulate appetitive responses. Numerous pharmacologi- thought to be difficult and perhaps impossible, stimulating a cal studies targeting different peptide systems as well as single set of long range inputs among many, is now relative- monoaminergic systems have found that the BNST plays a key ly straight-forward using optogenetic approaches. This has role in anxiety. For example, the Davis group has found that provided an avalanche of data demonstrating causal roles CRF in the BNST can potently enhance anxiety (Walker et al., for circuits in a variety of behaviors. However, despite the 2009b) and the Hammack group has found that PACAP signal- critical role that neuropeptide signaling plays in the regula- ing can alter stress responses (Kocho-Schellenberg et al., tion of behavior and physiology of the brain, there have 2014; Lezak et al., 2014a; 2014b). In support of this, recent been remarkably few studies demonstrating how peptide findings from several groups using optogenetic approaches release is causally linked to behaviors. This is likely due to have shown the BNST plays a role in anxiety (Jennings et al., both the different time scale by which peptides act on and 2013a; Kim et al., 2013), however these manuscripts also the modulatory nature of their actions.
    [Show full text]
  • Coordinated Changes in Energy Intake and Expenditure Following Hypothalamic Administration of Neuropeptides Involved in Energy Balance
    Europe PMC Funders Group Author Manuscript Int J Obes (Lond). Author manuscript; available in PMC 2010 January 01. Published in final edited form as: Int J Obes (Lond). 2009 July ; 33(7): 775–785. doi:10.1038/ijo.2009.96. Europe PMC Funders Author Manuscripts Coordinated changes in energy intake and expenditure following hypothalamic administration of neuropeptides involved in energy balance Nina M Semjonous*, Kirsty L Smith*, James RC Parkinson, David JL Gunner, Yong-Ling Liu, Kevin G Murphy, Mohammad A Ghatei, Stephen R Bloom, and Caroline J Small Department of Investigative Medicine, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK Abstract Objective—The hypothalamic control of energy balance is regulated by a complex network of neuropeptide-releasing neurons. Whilst the effect of these neuropeptides on individual aspects of energy homeostasis has been studied, the coordinated response of these effects has not been comprehensively investigated. We have simultaneously monitored a number of metabolic parameters following ICV administration of 1nmol and 3nmol of neuropeptides with established roles in the regulation of feeding, activity and metabolism. Ad libitum fed rats received the orexigenic neuropeptides neuropeptide Y (NPY), agouti-related protein (AgRP), melanin- concentrating hormone (MCH) or orexin-A. Overnight food deprived rats received an ICV injection of the anorectic peptides α-MSH, corticotrophin releasing factor (CRF) or neuromedin U (NMU). Results—Our results reveal the temporal sequence of the effects of these neuropeptides on both Europe PMC Funders Author Manuscripts energy intake and expenditure, highlighting key differences in their function as mediators of energy balance. NPY and AgRP increased feeding and decreased oxygen consumption, with the effects of AgRP being more prolonged.
    [Show full text]